Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 167,802 | 167,262 | 178,876 | 201,188 | 202,523 |
| Cost of Goods | 112,175 | 108,997 | 116,032 | 130,194 | 134,205 |
| Gross Profit | 55,627 | 58,265 | 62,844 | 70,994 | 68,318 |
| Operating Expenses | 11,603 | 7,574 | 16,257 | 18,773 | 13,350 |
| Operating Income | 44,199 | 51,688 | 46,619 | 52,415 | 55,173 |
| Interest Expense | 3,895 | 3,840 | 3,800 | 4,235 | 4,593 |
| Other Income | 0 | 0 | 0 | 2,829 | 0 |
| Pre-tax Income | 40,304 | 47,848 | 42,819 | 51,009 | 50,580 |
| Income Tax | 9,189 | 17,884 | 13,580 | 15,732 | 13,643 |
| Net Income Continuous | 31,115 | 29,964 | 29,239 | 35,277 | 36,937 |
| Minority Interests | 127 | 157 | 47 | 59 | 103 |
| Net Income | $30,988 | $29,807 | $29,192 | $35,218 | $36,834 |
| EPS Basic Total Ops | 0.67 | 0.65 | 0.64 | 0.77 | 0.80 |
| EPS Basic Continuous Ops | 0.68 | 0.65 | 0.64 | 0.77 | 0.80 |
| EPS Diluted Total Ops | 0.67 | 0.64 | 0.63 | 0.76 | 0.77 |
| EPS Diluted Continuous Ops | 0.67 | 0.65 | 0.63 | 0.76 | 0.77 |
| EBITDA(a) | $50,222 | $57,594 | $52,327 | $62,081 | $60,735 |